Retatrutide stays investigational as of 2026. It's not at all FDA-permitted and cannot be prescribed or compounded outside of clinical trial participation. Some compounding pharmacies advertise retatrutide availability by means of telehealth prescriptions. These statements violate federal law. Comprehension the legal framework governing pharmace